Literature DB >> 19669947

Macro role(s) of microRNAs in fragile X syndrome?

Xuekun Li1, Peng Jin.   

Abstract

Fragile X syndrome (FXS), the most common form of inherited mental retardation, is caused by the loss of functional fragile X mental retardation protein (FMRP). FMRP is an RNA-binding protein that can regulate the translation of specific mRNAs. It is known to regulate synaptic development through the regulation of local protein synthesis in synapses. MicroRNAs (miRNAs) are a class of small noncoding RNAs involved in almost every biological process. They exhibit spatiotemporal expression during brain development, and some miRNAs play important roles in neural development. A growing body of evidence now implicates the miRNA pathway in the molecular pathogenesis of FXS. Here we review the current state of knowledge about the microRNA pathway in neural development and the emergence of possible roles for miRNAs in FXS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669947     DOI: 10.1007/s12017-009-8081-2

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  88 in total

1.  Variability in FMRP and early development in males with fragile X syndrome.

Authors:  D B Bailey; D D Hatton; F Tassone; M Skinner; A K Taylor
Journal:  Am J Ment Retard       Date:  2001-01

2.  The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing.

Authors:  Eugene V Makeyev; Jiangwen Zhang; Monica A Carrasco; Tom Maniatis
Journal:  Mol Cell       Date:  2007-08-03       Impact factor: 17.970

3.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

4.  Quantitative proteomic analysis of primary neurons reveals diverse changes in synaptic protein content in fmr1 knockout mice.

Authors:  Lujian Liao; Sung Kyu Park; Tao Xu; Peter Vanderklish; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-30       Impact factor: 11.205

5.  FMR1 protein: conserved RNP family domains and selective RNA binding.

Authors:  C T Ashley; K D Wilkinson; D Reines; S T Warren
Journal:  Science       Date:  1993-10-22       Impact factor: 47.728

6.  MicroRNA processing pathway regulates olfactory neuron morphogenesis.

Authors:  Daniela Berdnik; Audrey P Fan; Christopher J Potter; Liqun Luo
Journal:  Curr Biol       Date:  2008-11-13       Impact factor: 10.834

Review 7.  MicroRNAs (miRNAs) in neurodegenerative diseases.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard W Rajeev
Journal:  Brain Pathol       Date:  2008-01       Impact factor: 6.508

8.  A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis.

Authors:  Gabriele Siegel; Gregor Obernosterer; Roberto Fiore; Martin Oehmen; Silvia Bicker; Mette Christensen; Sharof Khudayberdiev; Philipp F Leuschner; Clara J L Busch; Christina Kane; Katja Hübel; Frank Dekker; Christian Hedberg; Balamurugan Rengarajan; Carsten Drepper; Herbert Waldmann; Sakari Kauppinen; Michael E Greenberg; Andreas Draguhn; Marc Rehmsmeier; Javier Martinez; Gerhard M Schratt
Journal:  Nat Cell Biol       Date:  2009-05-24       Impact factor: 28.824

9.  Dicer is essential for mouse development.

Authors:  Emily Bernstein; Sang Yong Kim; Michelle A Carmell; Elizabeth P Murchison; Heather Alcorn; Mamie Z Li; Alea A Mills; Stephen J Elledge; Kathryn V Anderson; Gregory J Hannon
Journal:  Nat Genet       Date:  2003-10-05       Impact factor: 38.330

10.  Members of the miRNA-200 family regulate olfactory neurogenesis.

Authors:  Philip S Choi; Lisa Zakhary; Wen-Yee Choi; Sophie Caron; Ezequiel Alvarez-Saavedra; Eric A Miska; Mike McManus; Brian Harfe; Antonio J Giraldez; H Robert Horvitz; Alexander F Schier; Catherine Dulac
Journal:  Neuron       Date:  2008-01-10       Impact factor: 17.173

View more
  7 in total

Review 1.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 2.  Non-coding RNA networks underlying cognitive disorders across the lifespan.

Authors:  Irfan A Qureshi; Mark F Mehler
Journal:  Trends Mol Med       Date:  2011-03-15       Impact factor: 11.951

Review 3.  New perspectives on the biology of fragile X syndrome.

Authors:  Tao Wang; Steven M Bray; Stephen T Warren
Journal:  Curr Opin Genet Dev       Date:  2012-02-28       Impact factor: 5.578

Review 4.  Non-coding RNAs--novel targets in neurotoxicity.

Authors:  Tamara L Tal; Robert L Tanguay
Journal:  Neurotoxicology       Date:  2012-02-27       Impact factor: 4.294

5.  Structural studies of the tandem Tudor domains of fragile X mental retardation related proteins FXR1 and FXR2.

Authors:  Melanie A Adams-Cioaba; Yahong Guo; ChuanBing Bian; Maria F Amaya; Robert Lam; Gregory A Wasney; Masoud Vedadi; Chao Xu; Jinrong Min
Journal:  PLoS One       Date:  2010-11-02       Impact factor: 3.240

Review 6.  Diagnostic and therapeutic potential of microRNAs in neuropsychiatric disorders: Past, present, and future.

Authors:  Begum Alural; Sermin Genc; Stephen J Haggarty
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2016-04-09       Impact factor: 5.067

7.  Global Approaches to the Role of miRNAs in Drug-Induced Changes in Gene Expression.

Authors:  Jodi E Eipper-Mains; Betty A Eipper; Richard E Mains
Journal:  Front Genet       Date:  2012-06-13       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.